InVivo Therapeutics Holdings Alpha and Beta Analysis
| NVIVDelisted Stock | USD 1.38 0.07 5.34% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as InVivo Therapeutics Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in InVivo Therapeutics over a specified time horizon. Remember, high InVivo Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to InVivo Therapeutics' market risk premium analysis include:
Beta 0.52 | Alpha 0.004626 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
InVivo |
InVivo Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. InVivo Therapeutics market risk premium is the additional return an investor will receive from holding InVivo Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in InVivo Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate InVivo Therapeutics' performance over market.| α | 0 | β | 0.52 |
InVivo Therapeutics Fundamentals Vs Peers
Comparing InVivo Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze InVivo Therapeutics' direct or indirect competition across all of the common fundamentals between InVivo Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as InVivo Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of InVivo Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing InVivo Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare InVivo Therapeutics to competition |
| Fundamentals | InVivo Therapeutics | Peer Average |
| Return On Equity | -0.98 | -0.31 |
| Return On Asset | -0.54 | -0.14 |
| Current Valuation | (7.59 M) | 16.62 B |
| Shares Outstanding | 3.11 M | 571.82 M |
| Shares Owned By Insiders | 0.02 % | 10.09 % |
| Shares Owned By Institutions | 3.44 % | 39.21 % |
| Number Of Shares Shorted | 17.63 K | 4.71 M |
InVivo Therapeutics Opportunities
InVivo Therapeutics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About InVivo Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including InVivo or other delisted stocks. Alpha measures the amount that position in InVivo Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
InVivo Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of InVivo Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InVivo Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of InVivo Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of InVivo Therapeutics. Please utilize our Beneish M Score to check the likelihood of InVivo Therapeutics' management manipulating its earnings.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with InVivo Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |